BIOMAT Database Logo BIOMAT Database Logo

Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy. 1996

H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 "rescue" therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 "rescue" therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9 +/- 7.8 (SD) months (range 1-26 months). The actuarial 1-year graft survival rate was 86% compared with 66% for historical controls (P < 0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis.
January 1997, Transplant international : official journal of the European Society for Organ Transplantation,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
FK 506 rescue therapy for intractable liver allograft rejection.
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Prolongation of canine renal allograft survival by treatment with FK-506.
October 1987, Transplantation proceedings,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
FK 506 used as rescue therapy for refractory liver allograft rejection.
August 1994, Transplantation proceedings,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
FK 506 used as rescue therapy for human liver allograft recipients.
December 1991, Transplantation proceedings,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Tacrolimus (FK 506).
September 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.
August 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
February 1995, Clinical transplantation,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
April 1993, Transplantation proceedings,
H E Corey, and V Tellis, and R Schechner, and S M Greenstein
Effect of local immunosuppressive therapy with FK 506 on renal allograft survival in the mongrel dog.
November 1998, Transplantation proceedings,
Copied contents to your clipboard!